Evidence map›Paper›PMID 37516919›Full record

ArticleThe Journal of general physiology2023

Determinants of iFGF13-mediated regulation of myocardial voltage-gated sodium (NaV) channels in mouse.

Adrien Lesage, Maxime Lorenzini, Sophie Burel, Marine Sarlandie, Floriane Bibault, Cecilia Lindskog, Daniel Maloney, Jonathan R Silva, R Reid Townsend, Jeanne M Nerbonne and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of general physiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 4 countries.

Adrien LesageCNRS, INSERM, L'institut du Thorax , Nantes Université, Nantes, France.ORCID 0000-0002-8188-9168
Maxime LorenziniCNRS, INSERM, L'institut du Thorax , Nantes Université, Nantes, France.ORCID 0000-0001-5431-8274
Sophie BurelCNRS, INSERM, L'institut du Thorax , Nantes Université, Nantes, France.ORCID 0000-0003-0557-3396
Marine SarlandieCNRS, INSERM, L'institut du Thorax , Nantes Université, Nantes, France.ORCID 0009-0002-9887-0014
Floriane BibaultCNRS, INSERM, L'institut du Thorax , Nantes Université, Nantes, France.ORCID 0009-0001-8212-0908
Cecilia LindskogDepartment of Immunology, Genetics and Pathology, Cancer Precision Medicine, Uppsala University, Uppsala, Sweden.ORCID 0000-0001-5611-1015
Daniel MaloneyBioinformatics Solutions Inc. , Waterloo, ON, Canada.ORCID 0009-0002-3239-2937
Jonathan R SilvaDepartment of Biomedical Engineering, Washington University in St. Louis, St. Louis, MO, USA.ORCID 0000-0002-3696-3955
R Reid TownsendDepartment of Cell Biology and Physiology, Washington University Medical School, St. Louis, MO, USA.ORCID 0000-0002-0753-7594
Jeanne M NerbonneDepartment of Biomedical Engineering, Washington University in St. Louis, St. Louis, MO, USA.ORCID 0000-0001-8334-8499
Céline MarionneauCNRS, INSERM, L'institut du Thorax , Nantes Université, Nantes, France.ORCID 0000-0003-0962-9756
Centre National de la Recherche Scientifique · FRWashington University in St. Louis · USBioinformatics Solutions (Canada) · CAUppsala University · SE

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI AIMEE S JAMES · 2001 to 2026
$128.0M
WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
TrainingP41GM103422 · NIGMS · WASHINGTON UNIVERSITY · PI YARASHESKI, KEVIN E · 2012 to 2019
$12.0M
ION CHANNEL REGULATION AND MODULATION IN CARDIAC MUSCLER01HL034161 · NHLBI · WASHINGTON UNIVERSITY · PI NERBONNE, JEANNE M. · 1986 to 2015
$4.6M
Personalizing Class I anti-Arrhythmic Drug TherapyR01HL148803 · NHLBI · WASHINGTON UNIVERSITY · PI SILVA, JONATHAN R · 2020 to 2024
$3.2M
Post-Transcriptional Regulation of Myocardial Sodium ChannelsR01HL150637 · NHLBI · WASHINGTON UNIVERSITY · PI NERBONNE, JEANNE M., SILVA, JONATHAN R · 2020 to 2023
$2.3M
Molecular Determinants of Regional Differences in Human Ventricular Repolarization and RemodelingR01HL142520 · NHLBI · WASHINGTON UNIVERSITY · PI NERBONNE, JEANNE M. · 2019 to 2022
$1.6M
NCATS NIH HHS UL1 TR000448NCATS NIH HHS UL1 TR002345NCI NIH HHS P30 CA091842NHLBI NIH HHS R01 HL034161NHLBI NIH HHS R01 HL142520NHLBI NIH HHS R01 HL148803NHLBI NIH HHS R01 HL150637NIGMS NIH HHS P41 GM103422
6 · The paper itself

Abstract

Posttranslational regulation of cardiac NaV1.5 channels is critical in modulating channel expression and function, yet their regulation by phosphorylation of accessory proteins has gone largely unexplored. Using phosphoproteomic analysis of NaV channel complexes from adult mouse left ventricles, we identified nine phosphorylation sites on intracellular fibroblast growth factor 13 (iFGF13). To explore the potential roles of these phosphosites in regulating cardiac NaV currents, we abolished expression of iFGF13 in neonatal and adult mouse ventricular myocytes and rescued it with wild-type (WT), phosphosilent, or phosphomimetic iFGF13-VY. While the increased rate of closed-state inactivation of NaV channels induced by Fgf13 knockout in adult cardiomyocytes was completely restored by adenoviral-mediated expression of WT iFGF13-VY, only partial rescue was observed in neonatal cardiomyocytes after knockdown. The knockdown of iFGF13 in neonatal ventricular myocytes also shifted the voltage dependence of channel activation toward hyperpolarized potentials, a shift that was not reversed by WT iFGF13-VY expression. Additionally, we found that iFGF13-VY is the predominant isoform in adult ventricular myocytes, whereas both iFGF13-VY and iFGF13-S are expressed comparably in neonatal ventricular myocytes. Similar to WT iFGF13-VY, each of the iFGF13-VY phosphomutants studied restored NaV channel inactivation properties in both models. Lastly, Fgf13 knockout also increased the late Na+ current in adult cardiomyocytes, and this effect was restored with expression of WT and phosphosilent iFGF13-VY. Together, our results demonstrate that iFGF13 is highly phosphorylated and displays differential isoform expression in neonatal and adult ventricular myocytes. While we found no roles for iFGF13 phosphorylation, our results demonstrate differential effects of iFGF13 on neonatal and adult mouse ventricular NaV channels.

Indexed as

MyocardiumMyocytes, CardiacAdenoviridaeAnimalsFibroblast Growth FactorsMicefibroblast growth factor 13Fibroblast Growth Factors

Identifiers

PMID37516919
PMCPMC10374952
OpenAlexW4385387966

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.